These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3520306)

  • 21. Structure-activity relationships in the deacetylation of O-glucosides of N-hydroxy-N-arylacylamides by mammalian liver microsomes.
    Yoshioka T; Tatsunami R; Ohno H; Uematsu T
    Chem Biol Interact; 2001 Jul; 137(1):25-42. PubMed ID: 11518562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutagenicity of nitro- and amino-substituted phenazines in Salmonella typhimurium.
    Watanabe T; Hanasaki Y; Hirayama T; Fukui S
    Mutat Res; 1989 Mar; 225(3):75-82. PubMed ID: 2648139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutagenicity of nitro- and amino-substituted carbazoles in Salmonella typhimurium. III. Methylated derivatives of 9H-carbazole.
    André V; Boissart C; Sichel F; Gauduchon P; Le Talaër JY; Lancelot JC; Mercier C; Chemtob S; Raoult E; Tallec A
    Mutat Res; 1997 Mar; 389(2-3):247-60. PubMed ID: 9093391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutagenicity of nitro derivatives produced by exposure of dibenzofuran to nitrogen oxides.
    Watanabe T; Hirayama T
    Mutat Res; 1992 Sep; 283(1):35-43. PubMed ID: 1380661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutagenicity of 2-methylacrolein, 2-ethylacrolein and 2-propylacrolein in Salmonella typhimurium TA100. A comparative study.
    Neudecker T; Eder E; Deininger C; Henschler D
    Mutat Res; 1991 Dec; 264(4):193-6. PubMed ID: 1723498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic activation of 2,4-dinitrobiphenyl derivatives for their mutagenicity in Salmonella typhimurium TA98.
    Hirayama T; Iguchi K; Watanabe T
    Mutat Res; 1990 Mar; 243(3):201-6. PubMed ID: 2407954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutagenic activation of carcinogenic N-nitrosopropylamines by rat liver: evidence for a cytochrome P-450 dependent reaction.
    Mori Y; Yamazaki H; Toyoshi K; Makino T; Obara T; Yokose Y; Konishi Y
    Carcinogenesis; 1985 Mar; 6(3):415-20. PubMed ID: 3884171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutagenicity of some monoaromatic hydroxamic acids.
    Wei CI; Cohen MD; Swartz DD; Fernando SY; Corbett MD
    Toxicol Lett; 1985 Jan; 24(1):111-6. PubMed ID: 3883575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of the nitro group conformation on the rat liver microsomal metabolism and bacterial mutagenicity of 2- and 9-nitroanthracene.
    Fu PP; Heflich RH; Von Tungeln LS; Yang DT; Fifer EK; Beland FA
    Carcinogenesis; 1986 Nov; 7(11):1819-27. PubMed ID: 3533305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genotoxic activity of nitroaromatic explosives and related compounds in Salmonella typhimurium.
    Whong WZ; Edwards GS
    Mutat Res; 1984 Jun; 136(3):209-15. PubMed ID: 6377057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microsomal metabolism of 1-nitrobenzo[e]pyrene to a highly mutagenic K-region dihydrodiol.
    Fu PP; Heflich RH; Von Tungeln LS; Miranda HZ; Evans FE
    Carcinogenesis; 1988 Jun; 9(6):951-8. PubMed ID: 3286032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of the mutagenic effects of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ) in bacteria with rat-liver 9000 x g supernatant or monolayers of rat hepatocytes as an activation system.
    Holme JA; Brunborg G; Alexander J; Trygg B; Bjørnstad C
    Mutat Res; 1988 Jan; 197(1):39-49. PubMed ID: 3275882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of biotransformation of 2,4-dinitrotoluene on its mutagenic potential.
    Couch DB; Abernethy DJ; Allen PF
    Mutagenesis; 1987 Nov; 2(6):415-8. PubMed ID: 3328032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salmonella/microsome mutagenicity of monochloro derivatives of some di-, tri- and tetracyclic aromatic hydrocarbons.
    Löfroth G; Nilsson L; Agurell E; Sugiyama T
    Mutat Res; 1985 Mar; 155(3):91-4. PubMed ID: 3883156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salmonella/human S9 mutagenicity test: a collaborative study with 58 compounds.
    Hakura A; Shimada H; Nakajima M; Sui H; Kitamoto S; Suzuki S; Satoh T
    Mutagenesis; 2005 May; 20(3):217-28. PubMed ID: 15843387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of acetyl-CoA supplementation on the mutagenicity of benzidines in the Ames assay.
    Kennelly JC; Stanton CA; Martin CN
    Mutat Res; 1984 Jul; 137(1):39-45. PubMed ID: 6379437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative mutagenicity studies of azo dyes and their reduction products in Salmonella typhimurium.
    Krishna G; Xu J; Nath J
    J Toxicol Environ Health; 1986; 18(1):111-9. PubMed ID: 3517355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic activation of 3-nitroperylene in the Salmonella/S9 assay.
    Anderson JG; McCalla DR; Bryant DW; McCarry BE; Bromke AM
    Mutagenesis; 1987 Jul; 2(4):279-85. PubMed ID: 3325759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacterial mutagenicity investigation of epoxides: drugs, drug metabolites, steroids and pesticides.
    Glatt H; Jung R; Oesch F
    Mutat Res; 1983 Oct; 111(2):99-118. PubMed ID: 6355833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutagenicity studies in Salmonella typhimurium on some carcinogenic N-nitramines in vitro and in the host-mediated assay in rats.
    Khudoley V; Malaveille C; Bartsch H
    Cancer Res; 1981 Aug; 41(8):3205-10. PubMed ID: 7018677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.